MercachemSyncom announces organizational changes

Nijmegen, Groningen, Weert (The Netherlands), Prague (Czech Republic) –March 12, 2020

Following the successful acquisition of the cGMP drug substance production site in Weert earlier this year, MercachemSyncom, the leading mid-sized European drug-discovery contract research organization, is pleased to announce several changes in its organization to position the company for the next phase of growth and development. Please read the press release below for details regarding those changes.

Following the successful acquisition of the cGMP drug substance production site in Weert earlier this year, MercachemSyncom, the leading mid-sized European drug-discovery contract research organization, is pleased to announce several changes in its organization to position the company for the next phase of growth and development. Please read the press release below for details regarding those changes.

Scroll to top